We're building a specialist legal and regulatory firm for life sciences and healthcare, the companies at the frontier of regulated complexity, and the investors backing them (initially through ALTs Club, serving a select number of UHNWI and large Single-Family Offices with ~85BN AUM combined).

From Q3 2026, we're extending direct services to growth-stage life sciences and healthcare companies, delivering the regulatory and compliance work that typically goes to external counsel, at hourly rates that punish anything iterative.

Where others automate the routine, we encode the judgment. Our AI agents reason like senior GCs with 30 to 50 years of life sciences and healthcare experience at organisations like J&J, GSK, LabCorp, and SEKISUI Diagnostics, built with them, not from their documents.

Cross-jurisdictional complexity is growing. Data rules, promotional claims, and licensing frameworks are moving at different speeds in different markets. External counsel gives you a black-and-white memo. Then what?

The gap between legal advice and what's implementable in your business is where exposure sits. You need something strategic, not a 20-page memo that sits on a shelf.

Developing a cross-jurisdictional data compliance solution, three rules (retention, breach notification, cross-border transfer) designed to scale across 20+ jurisdictions, in partnership with international and boutique mid-market pharma and healthcare companies.

Also in development: cross-jurisdictional marketing claims review, traffic-light risk assessment for FDA/FTC-regulated promotional materials, encoded from 50 years of diagnostics promotional review experience.